Metabolic insight to illuminate causes of iron imbalanceAugust 06, 2008New insight into key players in iron metabolism has yielded a novel tool for distinguishing among root causes of iron overload or deficiency in humans, the researchers report in the August issue of Cell Metabolism, a publication of Cell Press. While the body needs iron to produce hemoglobin, a substance in red blood cells that enables them to carry oxygen, too much iron can build up and eventually damage organs. The balance of iron in mammals is controlled by a liver-produced hormone called hepcidin and the iron transporting receptor ferroportin, researchers knew. Hepcidin binds ferroportin to stimulate its break down, thereby lowering iron export. Too much hepcidin results in anemia; too little and the body doesn't rid itself of enough iron. (The most common human disease of iron overload is hereditary hemochromotosis, which affects about five out of 1000 Caucasians in the U.S., according to the National Institutes of Health.) Now, researchers have identified the critical hepcidin-binding domain (HBD) on ferroportin. By placing that binding site on a bead, they now have a very specific method for detecting hepcidin levels in human blood.
"We've identified the hepcidin-binding site," said Jerry Kaplan of the University of Utah, Salt Lake City. "It will allow the diagnosis of underlying inflammation to distinguish diseases of iron metabolism that stem from hepcidin versus those with other causes." Hepcidin was first known not for its effects on iron but for its antimicrobial action, explained Kaplan and his colleague Diane Ward, also of the University of Utah. The liver produces more of the hormone in response to inflammatory cytokines as a defense mechanism. Because microorganisms need iron, increases in hepcidin that lead to a decline in ferroportin and iron are believed to be antimicrobial, he explained. In addition to zeroing in on the hepcidin-binding site in the new study, Kaplan and Ward showed that their HBD assay can readily detect variations in serum hepcidin levels due to mutations in genes known to affect hepcidin levels as well as mutations in other genes involved in iron metabolism. While other tests for hepicidin have been developed, the new assay is unique in that it specifically identifies the hormone's biologically active form. Due to the remarkable degree of evolutionary conservation of the binding site, the new assay could also be used in other vertebrates, from cows to fish, they said. " This test narrows it down to [active hepcidin]," Ward added. "It can help us divine the effects of inflammation on body iron stores." The researchers made another unexpected discovery. Human hepcidin binds ferroportin at 37? Celsius, but not at 4?. The reason, they show, is that the hepcidin from humans changes its conformation at low temperatures. Most mammals never get that cold, so the physiological relevance wasn't clear. But, the researchers wondered what it might mean for other, cold-blooded vertebrates like fish that can live in very cold waters. They found that the hepcidin of zebrafish continued to bind at low temperatures, despite the fact that the hepcidin-binding domain of the fish was nearly identical to that from humans. The same was true of brown trout collected in the middle of the Utah winter, along with Alaskan nine-spine sticklebacks and a frog, they show. The difference between mammals and the fish seems to lie in a portion of the hepcidin structure outside of the binding domain. Their studies led to another evolutionary insight. Most mammals have just one hepcidin gene, but fish have multiple, earlier studies had shown. One of the fish hepcidins is a full-length, "mature" hepcidin, while the others are smaller versions. They now show that the full-length hepcidin of fish has little antimicrobial power against E. coli. Together with earlier evidence, the result suggest that mammalian hepcidin has both iron regulatory and antimicrobial activity, while fish hepcidin genes have evolved to separate these two functions, they said. Cell Press | |||||||||||||||||||||
|
Related Metabolism Current Events and Metabolism News Articles Study identifies causes of bone loss in breast cancer survivors Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss. Antibiotics Can Cause Pervasive, Persistent Changes to the Microbial Community in the Human Gut, MBL and Stanford Scientists Report Using a novel technique developed by Mitchell Sogin of the Marine Biological Laboratory (MBL) to identify different types of bacteria, scientists have completed the most precise survey to date of how microbial communities in the human gut respond to antibiotic treatment. Science teams at Cold Spring Harbor Laboratory identify 13 new tumor-suppressor genes in liver cancer Over the years, hunting for cancer-related genes and understanding how they work has been an important, although time-consuming, exercise. At Cold Spring Harbor Laboratory (CSHL), five different research groups have now combined their expertise to speed up the rate of discovering cancer-related genes and validating their function in living animals. Biomedical engineers' detective work reveals antibiotic mechanism A series of genetic clues led a team of Boston University biomedical engineers to uncover exactly how certain antibiotics kill bacteria. The findings could help rejuvenate the efficacy of older antibiotics and reveal new antibiotic targets within bacterial cells. Hormone shows promise in reversing Alzheimer's disease and stroke Saint Louis University researchers have identified a novel way of getting a potential treatment for Alzheimer's disease and stroke into the brain where it can do its work. SNPs affect folate metabolism in study of Puerto-Rican adults Researchers at Tufts University have gained further understanding of the genomic basis for altered folate metabolism and the content of uracil in blood DNA. Interaction between gene variants may alter brain function in schizophrenia A collaborative study led by investigators from Massachusetts General Hospital (MGH) is giving what may be the first look at how interactions between genes underlie a key symptom of schizophrenia, impaired working memory. Hormone therapy helps short children grow up Growth hormone treatment may significantly increase final height in children diagnosed with short stature, even in cases where the child is not growth hormone deficient, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). Drug mimics low-cal diet to ward off weight gain, boost running endurance A drug designed to specifically hit a protein linked to the life-extending benefits of a meager diet can essentially trick the body into believing food is scarce even when it isn't, suggests a new report in the November Cell Metabolism. Apelin hormone injections powerfully lower blood sugar By injecting a hormone produced by fat and other tissues into mice, researchers report in the November Cell Metabolism that they significantly lowered blood sugar levels in normal and obese mice. More Metabolism Current Events and Metabolism News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||